Senior Care Pharmacy Coalition

Senate hearing scrutinizes prescription drug costs

October 17, 2017 by Chain Drug Review Cost of Prescription Drugs: How the Delivery System Affects What Patients Pay, DIR fees, H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, Mark Merritt, National Community Pharmacists Association, Pharmaceutical Care Management Association, pharmacy benefit managers, prescription drug costs, S. 413, Senate HELP Committee, Senior Care Pharmacy Coalition Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Pharmacy benefit managers are a key focus of debate about elevated drug pricing that has come before a U.S. Senate committee. The National Community Pharmacists Association (NCPA) and the Senior Care Pharmacy Coalition (SCPC) called for PBM reform in written testimony submitted to a Senate Health, Education, Labor and Pensions (HELP) Committee hearing

PCMA explains drug price transparency

February 9, 2017 by Chain Drug Review Alan Rosenbloom, drug price transparency, H.R. 244, MAC Transparency Act, Mark Merritt, PBM, PCMA, Pharmaceutical Care Management Association, prescription drug costs, prescription drug pricing, Rep. Doug Collins, Senior Care Pharmacy Coalition, video Videos

With high prescription drug costs a pillar of the national debate on health care, the Pharmaceutical Care Management Association (PCMA) is trying to shed some light on drug pricing. The Washington, D.C.-based PBM trade group on Wednesday released a video titled, “What is drug price transparency?”. PCMA said the goal is to show how transparency